Development of diabetes in patients with the heterozygous pathogenic variant R46Q is likely explained by a combination of lower receptor binding affinity of the secreted GlnB22-insulin and some degree of impaired beta cell function (2, 6). The gene discussed is INS; the disease is diabetes mellitus.